Covetrus Financial Statements ()
|
|
Report date
|
|
|
03.03.2020 |
01.03.2021 |
30.09.2021 |
28.02.2022 |
30.06.2022 |
|
04.08.2022 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
3 976 |
4 339 |
|
4 575 |
|
|
4 649 |
Operating Income, bln rub |
|
|
-997.0 |
-69.0 |
|
-22.0 |
|
|
4.00 |
EBITDA, bln rub |
? |
|
-794.0 |
211.0 |
|
178.0 |
|
|
198.0 |
Net profit, bln rub |
? |
|
-1 019 |
-19.0 |
|
-86.0 |
|
|
-13.0 |
|
OCF, bln rub |
? |
|
103.0 |
53.0 |
|
102.0 |
|
|
64.0 |
CAPEX, bln rub |
? |
|
39.0 |
58.0 |
|
60.0 |
|
|
62.0 |
FCF, bln rub |
? |
|
64.0 |
-5.00 |
|
42.0 |
|
|
2.00 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
|
0.000 |
|
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
|
0.00% |
|
|
0.00% |
|
OPEX, bln rub |
|
|
808.0 |
867.0 |
|
881.0 |
|
|
883.0 |
Cost of production, bln rub |
|
|
3 227 |
3 541 |
|
3 717 |
|
|
3 767 |
R&D, bln rub |
|
|
0.000 |
0.000 |
|
0.000 |
|
|
0.000 |
Interest expenses, bln rub |
|
|
56.0 |
47.0 |
|
32.0 |
|
|
28.0 |
|
Assets, bln rub |
|
|
3 361 |
3 496 |
3 420 |
3 410 |
3 398 |
|
3 398 |
Net Assets, bln rub |
? |
|
1 256 |
1 537 |
1 502 |
1 511 |
1 505 |
|
1 505 |
Debt, bln rub |
|
|
1 187 |
1 069 |
1 073 |
1 046 |
1 049 |
|
1 049 |
Cash, bln rub |
|
|
130.0 |
290.0 |
187.0 |
183.0 |
87.0 |
|
87.0 |
Net debt, bln rub |
|
|
1 057 |
779.0 |
886.0 |
863.0 |
962.0 |
|
962.0 |
|
Ordinary share price, rub |
|
|
13.2 |
28.7 |
18.1 |
20.0 |
20.8 |
|
20.8 |
Number of ordinary shares, mln |
|
|
107.0 |
118.0 |
|
137.0 |
|
|
140.0 |
|
Market cap, bln rub |
|
|
1 412 |
3 391 |
0 |
2 736 |
0 |
|
2 905 |
EV, bln rub |
? |
|
2 469 |
4 170 |
886 |
3 599 |
962 |
|
3 867 |
Book value, bln rub |
|
|
-541 |
-205 |
-224 |
-175 |
-143 |
|
-143 |
|
EPS, rub |
? |
|
-9.52 |
-0.16 |
|
-0.63 |
|
|
-0.09 |
FCF/share, rub |
|
|
0.60 |
-0.04 |
|
0.31 |
|
|
0.01 |
BV/share, rub |
|
|
-5.06 |
-1.74 |
|
-1.28 |
|
|
-1.02 |
|
EBITDA margin, % |
? |
|
-20.0% |
4.86% |
|
3.89% |
|
|
4.26% |
Net margin, % |
? |
|
-25.6% |
-0.44% |
|
-1.88% |
|
|
-0.28% |
FCF yield, % |
? |
|
4.53% |
-0.15% |
0.00% |
1.54% |
0.00% |
|
0.07% |
ROE, % |
? |
|
-81.1% |
-1.24% |
0.00% |
-5.69% |
0.00% |
|
-0.86% |
ROA, % |
? |
|
-30.3% |
-0.54% |
0.00% |
-2.52% |
0.00% |
|
-0.38% |
|
P/E |
? |
|
-1.39 |
-178.5 |
|
-31.8 |
|
|
-223.5 |
P/FCF |
|
|
22.1 |
-678.3 |
|
65.1 |
|
|
1 453 |
P/S |
? |
|
0.36 |
0.78 |
|
0.60 |
|
|
0.62 |
P/BV |
? |
|
-2.61 |
-16.5 |
0.00 |
-15.6 |
0.00 |
|
-20.3 |
EV/EBITDA |
? |
|
-3.11 |
19.8 |
|
20.2 |
|
|
19.5 |
Debt/EBITDA |
|
|
-1.33 |
3.69 |
|
4.85 |
|
|
4.86 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
0.00% |
|
|
0.00% |
|
CAPEX/Revenue, % |
|
|
0.98% |
1.34% |
|
1.31% |
|
|
1.33% |
|
Covetrus shareholders |